Last reviewed · How we verify
Sentinel Lymph Node Mapping with Double Tracer and Double Injection Sites in Early-Stage Endometrium Cancer
The aim of this prospective study is to investigate whether the detection rate of sentinel lymph node (SLN) with double tracer injected at two different sites may be increased compared to the standard use of a single tracer with single site (cervix) injection in early-stage endometrial cancer.
Details
| Lead sponsor | Istanbul University |
|---|---|
| Phase | NA |
| Status | RECRUITING |
| Enrolment | 100 |
| Start date | 2023-07-01 |
| Completion | 2026-05 |
Conditions
- Sentinel Lymph Node
- Endometrial Cancer
Interventions
- Sentinel Lymph Node Mapping With Double Tracer and Double Injection Sites in Early-Stage Endometrium Cancer
- charcoal injection to uterus to map sentinel lymph nodes
Primary outcomes
- Detection rate of sentinel lymph nodes with double tracer in early stage endometrial carcinoma — From the day of surgery to final pathology report (2 weeks)
Detection rates of sentinel lymph nodes for both tracers in every pelvic and paraaortic lymph node basin are the primary outcome of the study.Sentinel lymph node detection rates of each region (pelvic, obturator, inframesenteric para-aortic, supra-mesenteric - infrarenal para-aortic), bilaterality/ unilaterality and staining with single or double tracer will be discussed compared to literature data.
Countries
Turkey (Türkiye)